The current institutional shareholding score of Kura Oncology Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 103.35%, representing a quarter-over-quarter increase of 4.16%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.78% of shares outstanding, with 0.15% decrease in holdings.